Consensus Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-01-17 pm EST			5-day change	1st Jan Change
147.03 ^USD	-0.50%		+1.77%	+1.67%

Jan. 20	Sumitomo Pharma Co., Ltd. Announces Agreement on Co-Promotion Collaboration Partner for Marketing of Pplat Xeplion and Xeplion Trial in Japan with Johnson & Johnson	CI
Jan. 17	S&P 500 Logs 2.9% Weekly Gain on Easing Inflationary Pressures, Strong Bank Earnings	MT

Evolution of the Average Target: Johnson & Johnson

average-target-price-chart JOHNSON-JOHNSON

Evolution of the Target Price: Johnson & Johnson

target-price-consensus-chart JOHNSON-JOHNSON

Changes in Analyst Recommendations: Johnson & Johnson

c5aaaec6b600fb19d5.UQSMBf5nTM1jNi5bbjG8NDAn09KokcDXR4iv5Te-GG8.HX3cf4YSPptbZB0cNnbOZWIep5XG-vGgNeXVsHzbVA0pdKFnqRAqmCJAWQ~090a4526f70aa8871af053e056833d4a

Analysts' recommendations: Johnson & Johnson

BofA Securities Adjusts Johnson & Johnson Price Target to $160 From $166, Maintains Neutral Rating	Jan. 17	MT
Goldman Sachs Adjusts Price Target on Johnson & Johnson to $158 From $159, Keeps Neutral Rating	Jan. 10	MT
Bernstein Adjusts Price Target on Johnson & Johnson to $160 From $177, Maintains Market Perform Rating	Jan. 08	MT
Citigroup Adjusts Price Target on Johnson & Johnson to $175 From $185, Keeps Buy Rating	Dec. 11	MT
J&J: positive CHMP opinion for Lazcluze in lung cancer	Nov. 18	CF
Wolfe Research Initiates Johnson & Johnson at Outperform With $190 Price Target	Nov. 15	MT
Guggenheim Adjusts Johnson & Johnson's Price Target to $162 From $156, Keeps Neutral Rating	Nov. 06	MT
Daiwa Securities Adjusts Price Target on Johnson & Johnson to $170 From $150, Maintains Neutral Rating	24-10-22	MT
Argus Adjusts Price Target on Johnson & Johnson to $185 From $180	24-10-17	MT
Goldman Sachs Lowers Price Target on Johnson & Johnson to $159 From $162	24-10-16	MT
RBC Capital Adjusts Price Target on Johnson & Johnson to $181 From $178, Maintains Outperform Rating	24-10-16	MT
Wells Fargo Adjusts Price Target on Johnson & Johnson to $166 From $163, Maintains Equalweight Rating	24-10-16	MT
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $175 From $169, Maintains Equalweight Rating	24-10-16	MT
Bernstein Adjusts Price Target on Johnson & Johnson to $177 From $171, Maintains Market Perform Rating	24-10-16	MT
Citigroup Adjusts Price Target on Johnson & Johnson to $185 From $180, Maintains Buy Rating	24-10-16	MT
Stifel Raises Johnson & Johnson's Price Target to $170 From $160	24-10-15	MT
RBC Capital Adjusts Price Target on Johnson & Johnson to $178 From $175	24-10-08	MT
Goldman Sachs Adjusts Price Target on Johnson & Johnson to $162 From $155	24-10-08	MT
JPMorgan Adjusts Price Target on Johnson & Johnson to $185 From $180, Maintains Neutral Rating	24-10-02	MT
HSBC Raises Price Target on Johnson & Johnson to $180 From $174	24-09-13	MT
Analyst recommendations: CrowdStrike, Johnson & Johnson, Netflix, Nvidia, Snap...	24-07-23
Daiwa Downgrades Johnson & Johnson to Neutral From Outperform, Adjusts Price Target to $150 From $160	24-07-23	MT
Guggenheim Adjusts Johnson & Johnson's Price Target to $156 From $160, Maintains Neutral Rating	24-07-22	MT
HSBC Adjusts Price Target on Johnson & Johnson to $174 From $170, Maintains Buy Rating	24-07-19	MT
Goldman Sachs Adjusts Price Target on Johnson & Johnson to $155 From $160	24-07-18	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	JOHNSON & JOHNSON					+16.53%
	ELI LILLY AND COMPANY					+34.69%
	NOVO NORDISK A/S					+44.32%
	ABBVIE INC.					+16.54%
	MERCK & CO., INC.					+28.22%
	ROCHE HOLDING AG					+14.34%
	ASTRAZENECA PLC					+30.07%
	NOVARTIS AG					+15.78%
	PFIZER, INC.					+18.54%
	AMGEN INC.					+16.58%
	Average					+23.56%
	Weighted average by Cap.					+26.03%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

147.03USD

Average target price

171.34USD

Spread / Average Target

+16.53%

High Price Target

190.00USD

Spread / Highest target

+29.23%

Low Price Target

155.00USD

Spread / Lowest Target

+5.42%

Analyst Consensus Detail

Consensus revision (last 18 months)

consensus-revision-chart JOHNSON-JOHNSON

Analysts covering the company

BofA Securities
Goldman Sachs
Bernstein
Citigroup
Wolfe Research
Guggenheim
Daiwa Securities
Argus
RBC Capital Markets
Wells Fargo Securities
Morgan Stanley
Stifel Nicolaus
JPMorgan Chase
HSBC
Redburn Atlantic
DZ Bank
Raymond James
UBS
Atlantic Equities
Barclays
Credit Suisse
SVB Securities LLC
DA Davidson
SVB Financial
Sanford Bernstein
Cantor Fitzgerald
J.P. Morgan Chase
Cowen
SVB Leerink
RBC	Brandon Henry